award

Deciphering the structural determinants of response and resistance to HER2-targeted antibody-drug conjugates and tyrosine kinase inhibitors for HER2-mutant Non-Small Cell Lung Cancer

  • Award Number: R01CA287279

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 04/01/2025

  • PERIOD OF PERFORMANCE END DATE: 03/31/2030